Table 2 In vivo anti-hyperlipidaemic study
S. No. | Group | Treatment | Dose (mg/kg) | Route of administration |
|---|---|---|---|---|
1 | I | Triton | 300 | Injected intraperitoneal |
2 | II | FB:BZ cocrystals | 25 | Oral route |
3 | III | FB:BZ cocrystals | 50 | Oral route |
4 | IV | FB | 50 | Oral route |
S. No. | Group | Treatment | Dose (mg/kg) | Route of administration |
|---|---|---|---|---|
1 | I | Triton | 300 | Injected intraperitoneal |
2 | II | FB:BZ cocrystals | 25 | Oral route |
3 | III | FB:BZ cocrystals | 50 | Oral route |
4 | IV | FB | 50 | Oral route |